Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CNBX PHARMACEUTICALS INC. (CNBX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CNBX PHARMACEUTICALS INC. (CNBX), most recent 12 months reported: revenue $0, net loss $462.09K, free cash flow -$171.31K. Latest balance sheet on file: liquid cash $9.49K, total debt $1.17M, net cash -$1.16M. From SEC filings. Others in Pharmaceutical Preparations: Cellectar Biosciences, Inc. · CLIMB BIO, INC. · SNOWDRIFT PARENT CORPORATION · COMPASS PATHWAYS PLC · CNS Pharmaceuticals, Inc. · CONTEXT THERAPEUTICS INC. · COCRYSTAL PHARMA, INC. · Cogent Biosciences, Inc.

Stock screener

Watchlist